Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 1
2015 3
2017 1
2018 1
2019 1
2020 1
2021 1
2022 1
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Epigenetic Profiling and Response to CD19 Chimeric Antigen Receptor T-Cell Therapy in B-Cell Malignancies.
Garcia-Prieto CA, Villanueva L, Bueno-Costa A, Davalos V, González-Navarro EA, Juan M, Urbano-Ispizua Á, Delgado J, Ortiz-Maldonado V, Del Bufalo F, Locatelli F, Quintarelli C, Sinibaldi M, Soler M, Castro de Moura M, Ferrer G, Urdinguio RG, Fernandez AF, Fraga MF, Bar D, Meir A, Itzhaki O, Besser MJ, Avigdor A, Jacoby E, Esteller M. Garcia-Prieto CA, et al. Among authors: meir a. J Natl Cancer Inst. 2022 Mar 8;114(3):436-445. doi: 10.1093/jnci/djab194. J Natl Cancer Inst. 2022. PMID: 34581788 Free PMC article.
Genotoxicity associated with retroviral CAR transduction of ATM-deficient T cells.
Rozenbaum M, Fluss R, Marcu-Malina V, Sarouk I, Meir A, Elitzur S, Zinger T, Jacob-Hirsch J, Glick Saar E, Rechavi G, Jacoby E. Rozenbaum M, et al. Among authors: meir a. Blood Cancer Discov. 2024 May 15. doi: 10.1158/2643-3230.BCD-23-0268. Online ahead of print. Blood Cancer Discov. 2024. PMID: 38747501
Early and late hematologic toxicity following CD19 CAR-T cells.
Fried S, Avigdor A, Bielorai B, Meir A, Besser MJ, Schachter J, Shimoni A, Nagler A, Toren A, Jacoby E. Fried S, et al. Among authors: meir a. Bone Marrow Transplant. 2019 Oct;54(10):1643-1650. doi: 10.1038/s41409-019-0487-3. Epub 2019 Feb 26. Bone Marrow Transplant. 2019. PMID: 30809033
Mitochondrial augmentation of CD34+ cells from healthy donors and patients with mitochondrial DNA disorders confers functional benefit.
Jacoby E, Ben Yakir-Blumkin M, Blumenfeld-Kan S, Brody Y, Meir A, Melamed-Book N, Napso T, Pozner G, Saadi E, Shabtay-Orbach A, Yivgi-Ohana N, Sher N, Toren A. Jacoby E, et al. Among authors: meir a. NPJ Regen Med. 2021 Sep 24;6(1):58. doi: 10.1038/s41536-021-00167-7. NPJ Regen Med. 2021. PMID: 34561447 Free PMC article.
Locally produced CD19 CAR T cells leading to clinical remissions in medullary and extramedullary relapsed acute lymphoblastic leukemia.
Jacoby E, Bielorai B, Avigdor A, Itzhaki O, Hutt D, Nussboim V, Meir A, Kubi A, Levy M, Zikich D, Zeltzer LA, Brezinger K, Schachter J, Nagler A, Besser MJ, Toren A. Jacoby E, et al. Among authors: meir a. Am J Hematol. 2018 Dec;93(12):1485-1492. doi: 10.1002/ajh.25274. Epub 2018 Sep 26. Am J Hematol. 2018. PMID: 30187944 Free article. Clinical Trial.
Bioactive magnetic near Infra-Red fluorescent core-shell iron oxide/human serum albumin nanoparticles for controlled release of growth factors for augmentation of human mesenchymal stem cell growth and differentiation.
Levy I, Sher I, Corem-Salkmon E, Ziv-Polat O, Meir A, Treves AJ, Nagler A, Kalter-Leibovici O, Margel S, Rotenstreich Y. Levy I, et al. Among authors: meir a. J Nanobiotechnology. 2015 May 7;13:34. doi: 10.1186/s12951-015-0090-8. J Nanobiotechnology. 2015. PMID: 25947109 Free PMC article.
13 results